| Literature DB >> 19052359 |
Mark A Stead1, Gareth O Rosbrook, Jonathan M Hadden, Chi H Trinh, Stephen B Carr, Stephanie C Wright.
Abstract
BCL6 is a transcriptional repressor that is overexpressed in diffuse large B-cell lymphoma and follicular lymphoma. The N-terminal POZ domain of BCL6 interacts with transcriptional corepressors and targeting these associations is a promising therapeutic strategy. Previous structural studies of the BCL6 POZ domain have used a mutant form because of the low solubility of the wild-type recombinant protein. A method for the purification and crystallization of the wild-type BCL6 POZ domain is described and the crystal structure to 2.1 A resolution is reported. This will be relevant for the design of therapeutics that target BCL6 POZ-domain interaction interfaces.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19052359 PMCID: PMC2593701 DOI: 10.1107/S1744309108036063
Source DB: PubMed Journal: Acta Crystallogr Sect F Struct Biol Cryst Commun ISSN: 1744-3091